Aldehyde dehydrogenase as an alternative to enumeration of total and viable CD34+ cells in autologous hematopoietic progenitor cell transplantation

Cytotherapy

Volumn 13, Issue 10, 2011, Pages 1256-1258

  Veeraputhiran, Muthu ^a   Katragadda, Lakshmikanth ^a   Balamurugan, Appathurai ^b   Cottler Fox, Michele ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

aldehyde dehydrogenase; CD34; engraftment; transplant; viability

Indexed keywords

ALDEHYDE DEHYDROGENASE; BIOLOGICAL MARKER; BORTEZOMIB; CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; LENALIDOMIDE; MELPHALAN; THALIDOMIDE;

APHERESIS; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CD34 SELECTION; CELL COUNT; CELL VIABILITY; CLASSICAL HODGKIN LYMPHOMA; CRYOPRESERVATION; ENGRAFTMENT; FEMALE; FLOW CYTOMETRY; FREEZE THAWING; HODGKIN DISEASE; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; MEDICAL RECORD REVIEW; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; THROMBOCYTE;

EID: 80054741209     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2011.602340     Document Type: Article

References (21)

1. Randall TD, Weissman IL. Characterization of a population of cells in the bone marrow that phenotypically mimics hematopoietic stem cells: Resting stem cells or mystery population? Stem Cells. 1998;16:38-48.
2. Osawa M, Hanada, K, Hamada H, Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34- low/negative hematopoietic stem cell. Science. 1996;273: 242-5. (Pubitemid 26285891)
3. Goodell MA, Rosenzweig M, Kim H, Marks DF, De-Maria M, Paradis G, et al. Dye effl ux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med. 1997;3: 1337-45. (Pubitemid 28011033)
4. Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick JE. A newly discovered class of human hematopoietic cells with SCIDrepopulating activity. Nat Med. 1998;4:1038-45. (Pubitemid 28417336)
5. Jones RJ, Collector MI, Barber JP, Vala MS, Fackler MJ, May WS, et al. Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity. Blood. 1996;88:487-91. (Pubitemid 26240380)
6. Gentry T, Foster S, Winstead L, Deibert E, Fiordalisi M, Balber A. Simultaneous isolation of human BM hematopoietic, endothelial and mesenchymal progenitor cells by fl ow sorting based on aldehyde dehydrogenase activity: Implications for cell therapy Cytotherapy. 2007;9:259-74.
7. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by fl ow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother. 1996;5:213-26.
8. Sieff CA, Mulligan RC, Johnson RP. Identifi cation of Viable and Progenitor cells with Aldefl uor. Stemcell Technologies Technical Bulletin. www.stemcell.com: Accessed 10 May 2011.
9. Draper NR, Smith H. Applied Regression Analysis. 3rd ed. New York: Wiley; 1998.
10. Gunduz E, Demirel G, Bal C, Gulbas Z. Evaluation of mobilized peripheral stem cells according to CD34 and aldehyde dehydrogenase expression and effect of SSC lo ALDH br cells on hematopoietic recovery. Cytotherapy. 2010;12:1006-12.
11. Lioznov M, Dellbrü gger C, Sputtek A, Fehse B, Kroger N, Zander AR. Transportation and cryopreservation may impair haematopoietic stem cell function and engraftment of allogeneic PBSCs, but not BM. Bone Marrow Transplant. 2008;42:121-8.
12. Cai J, Weiss ML, Rao MS. In search of stemness. Exp Hematol. 2004;32:585-98.
13. Jones R, Barber J, Vala M, Collector MI, Kaufmann SH, Ludeman SM, et al. Assessment of aldehyde dehydrogenase in viable cells. Blood. 1995;85:2742-6.
14. Storms RW, Green PD, Saford KM, Niedzwiecki D, Cogle CR, Colvin OM, et al. Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34. Blood. 2005;106:95-102. (Pubitemid 40967179)
15. Fallon P, Gentry T, Balber AE, Boulware D, Janssen W, Smilee R, et al. Mobilized peripheral blood SSC lo ALDH br cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantation. Br J Haematol. 2003;122:99-108. (Pubitemid 36819344)
16. Lioznov MV, Freiberger P, Krö g er N, Zander AR, Fehse B. Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants. Bone Marrow Transplant. 2005;35:909-14.
17. Gianni AM, Bregni M, Siena S, Villa S, Sciorelli A, Ravagnani F, et al. Rapid and complete hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells: A changing role for high dose chemo-radiotherapy? Hematol Oncol. 1989;7:139-48.
18. de Boer F, Drager AM, Pinedo HM, Kessler FL, van der Wall E, Jonkhoff AR, et al. Extensive early apoptosis in frozenthawed CD34-positive stem cells decreases threshold doses for haematological recovery after autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplant. 2002;29:249-55. (Pubitemid 34189518)
19. Macey, MG, McCarthy DA, van Agthoven A, Newland AC. How should CD34+ cells be analysed? A study of three classes of antibody and fi ve leucocyte preparation procedures. J Immunol Methods. 1997;204:175-88. (Pubitemid 27262011)
20. Allan DS, Keeney M, Howson-Jan K, Popma J, Weir K, Bhatia M, et al. Number of viable CD34 (+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation. Bone Marrow Transplant. 2002;29:967-72. (Pubitemid 34845951)
21. Olivero S, Alario T, Ladaique P, Haccoun M, Viens P, Blaise D, et al. CD34+ cell enumeration in peripheral blood and apheresis samples, using two laboratory diagnostic kits or an institutional protocol. Bone Marrow Transplant. 1999;23:387-94. (Pubitemid 29105963)